Table 3 Univariable analysis of clinical and CMR characteristics for prediction of MACE
MACE | Cardiovascular Mortality | |||
|---|---|---|---|---|
Hazard Ratio (95% CI) | p value | Hazard Ratio (95% CI) | p value | |
Age | 1.02 (0.99–1.05) | 0.14 | 1.08 (1.03–1.12) | 0.001 |
Male | 1.15 (0.68–1.93) | 0.61 | 0.68 (0.37–1.26) | 0.22 |
BMI | 1.03 (0.96–1.10) | 0.41 | 0.98 (0.89–1.07) | 0.60 |
Diabetes mellitus | 4.39 (2.49–7.71) | < 0.001 | 4.87 (2.27–10.5) | < 0.001 |
Hypertension | 1.44 (0.82–2.53) | 0.21 | 1.94 (0.87–4.35) | 0.11 |
Dyslipidemia | 0.66 (0.42–1.03) | 0.07 | 0.56 (0.31–1.01) | 0.05 |
Current or previous smoking | 1.61 (0.94–2.75) | 0.09 | 1.05 (0.47–2.35) | 0.91 |
Family history of CAD | 1.03 (0.45–2.38) | 0.94 | 1.92 (0.81–4.53) | 0.14 |
eGFR, per 10 units | 0.73 (0.50–0.83) | 0.012 | 0.53 (0.37–0.68) | < 0.001 |
Time between CKD diagnosis and CMR exam | 1.62 (0.91–2.59) | 0.19 | 1.99 (0.91–4.40) | 0.10 |
Dyspnea | 2.68 (1.60–4.47) | < 0.001 | 6.07 (3.36–11.0) | < 0.001 |
LVEF, per 10% | 0.88 (0.72–1.10) | 0.28 | 1.22 (0.88–1.70) | 0.24 |
LV end-diastolic volume index, per 10 ml/m2 | 0.96 (0.81–1.14) | 0.64 | 0.86 (0.68–1.08) | 0.19 |
LV end-systolic volume index, per 10 ml/m2 | 0.78 (0.50–1.21) | 0.27 | 0.44 (0.25–0.73) | 0.002 |
Presence of unrecognized MI | 4.31 (2.74–6.79) | < 0.001 | 4.27 (2.35–7.75) | < 0.001 |
Number of segments with unrecognized MI | 2.09 (1.88–2.33) | < 0.001 | 2.15 (1.87–2.47) | < 0.001 |
Presence of inducible ischemia | 12.5 (7.50–20.8) | < 0.001 | 9.76 (5.19–18.4) | < 0.001 |
Number of segments with ischemia | 1.68 (1.55–1.83) | < 0.001 | 1.58 (1.40–1.77) | < 0.001 |